Shares of Agilon Health, Inc. (NYSE:AGL - Get Free Report) gapped down before the market opened on Tuesday. The stock had previously closed at $116.75, but opened at $111.94. Agilon Health shares last traded at $113.8950, with a volume of 36,491 shares changing hands.
Wall Street Analyst Weigh In
Several brokerages have recently weighed in on AGL. Barclays set a $111.00 price target on Agilon Health and gave the company an "equal weight" rating in a research report on Thursday, August 6th. JPMorgan Chase & Co. boosted their price objective on shares of Agilon Health from $31.00 to $85.00 and gave the company an "underweight" rating in a research note on Monday, August 24th. StoneX upped their target price on shares of Agilon Health from $140.00 to $145.00 and gave the stock a "buy" rating in a report on Wednesday, November 11th. Weiss Ratings reiterated a "sell (e+)" rating on shares of Agilon Health in a research note on Monday, August 24th. Finally, Robert W. Baird set a $116.00 price target on shares of Agilon Health in a report on Thursday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $107.38.
Read Our Latest Analysis on AGL
Agilon Health Trading Down 0.8%
The stock has a market cap of $1.95 billion, a P/E ratio of -20.87 and a beta of 3.10. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.13 and a current ratio of 1.13. The stock has a 50-day moving average price of $91.28 and a 200-day moving average price of $69.46.
Agilon Health (NYSE:AGL - Get Free Report) last posted its quarterly earnings data on Wednesday, November 4th. The company reported $1.97 earnings per share for the quarter, topping the consensus estimate of ($1.23) by $3.20. The company had revenue of $1.52 billion for the quarter, compared to analysts' expectations of $1.46 billion. Agilon Health had a negative net margin of 1.45% and a negative return on equity of 51.97%. On average, equities research analysts expect that Agilon Health, Inc. will post -1.87 EPS for the current year.
Hedge Funds Weigh In On Agilon Health
A number of institutional investors have recently made changes to their positions in the stock. Sterling Capital Management LLC purchased a new position in Agilon Health in the third quarter worth $33,000. Root Financial Partners LLC purchased a new stake in Agilon Health during the third quarter valued at about $57,000. State of Alaska Department of Revenue purchased a new stake in Agilon Health during the third quarter valued at about $64,000. Allworth Financial LP bought a new stake in Agilon Health during the second quarter worth about $114,000. Finally, Proficio Capital Partners LLC bought a new stake in Agilon Health during the second quarter worth about $210,000.
Agilon Health Company Profile
(
Get Free Report)
Agilon Health is a U.S. healthcare company that partners with primary care physicians to provide care for patients enrolled in Medicare Advantage plans. Its model is designed to help physician groups move from traditional fee-for-service care toward value-based care, in which providers are rewarded for improving patients' health and coordinating their care. The company provides participating physician groups with clinical, operational, technology and administrative support, along with resources to manage patient populations and coordinate care across local healthcare networks.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Agilon Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.
While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.